Has Mary Katherine Thrower received payments from drug or device companies?

Yes. Drug and device makers reported $3,254 in general payments to Mary Katherine Thrower across 180 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mary Katherine Thrower did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mary Katherine Thrower come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mary Katherine Thrower

Psychiatry · Cullman, ALNPI 1578973954

Payments from drug & device makers

$3,254in general payments, 2019–2025

Across 180 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$704
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$423
Supernus Pharmaceuticals, Inc.$322
Ironshore Pharmaceuticals Inc.$263
Otsuka America Pharmaceutical, Inc.$261
Bausch Health US, LLC$241
plus $1K from 16 others

What the payments were for

Food & beverage$3,254100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	54	$704
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	24	$423
Supernus Pharmaceuticals, Inc.	11	$322
Ironshore Pharmaceuticals Inc.	5	$263
Otsuka America Pharmaceutical, Inc.	15	$261
Bausch Health US, LLC	16	$241
Johnson & Johnson	7	$166
Alkermes, Inc.	7	$147
Corium, LLC	7	$113
Almatica Pharma LLC	5	$100
Axsome Therapeutics, Inc.	6	$90
Teva Pharmaceuticals USA, Inc.	4	$68
Lundbeck LLC	3	$67
Takeda Pharmaceuticals U.S.A., Inc.	3	$59
Neurocrine Biosciences, Inc.	2	$51
Neos Therapeutics, LP	2	$34
Neuronetics, Inc.	2	$33
Tris Pharma Inc	2	$29
Adlon Therapeutics L.p.	2	$26
Vanda Pharmaceuticals Inc.	1	$25
Eisai Inc.	1	$16
Shire North American Group Inc	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Jornay PM 20mg capsules (Bottle of 100)$127

How this compares

$3,254 in reported general payments places this provider in the 75th percentile of 400 psychiatry providers in Alabama.

See all psychiatry providers in Alabama →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Aripiprazole	20	$3,862
Vilazodone Hcl	15	$2,754
Buspirone Hcl	45	$1,269
Duloxetine Hcl	38	$1,148
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	15	$1,129
Quetiapine Fumarate	50	$1,064
Trazodone Hcl	48	$877
Venlafaxine Hcl ErVenlafaxine Hcl	16	$692
Bupropion XlBupropion Hcl	27	$689
Carbamazepine	13	$576
Lamotrigine	26	$441
Prazosin Hcl	13	$393
Olanzapine	14	$276
Citalopram HbrCitalopram Hydrobromide	38	$276
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	11	$230

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Almatica Pharma LLCSertraline Hcl	$100	$13812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 400 psychiatry providers in Alabama.

Other psychiatry in Cullman

Ajmal KhanCullman$7K
Matthew MacalusoBirmingham$2.8M
Richard SheltonBirmingham$2.4M
Michael FalolaTrussville$2.2M
Armand SchachterBirmingham$758K
Stephen HughesBirmingham$683K
Leesha Ellis CoxBirmingham$653K
Godehard OepenBirmingham$516K
Lori DavisTuscaloosa$515K
Scariya KumaramangalamHuntsville$440K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →